Sarrazin Clement, Windisch Olivier Laurent, Baron Maximilien, Boillot Bernard, Thuillier Caroline, Lefevre Chloé, Perrouin-Verbe Brigitte, Ruffion Alain, Perrouin-Verbe Marie-Aimee
Univ. Grenoble Alpes, Chirurgie urologique et de la transplantation rénale, CHU Grenoble Alpes, 38000 Grenoble, France.
Division of Urologic Surgery, Geneva University Hospital, Genève, Switzerland.
J Urol. 2023 Jun;209(6):1176-1183. doi: 10.1097/JU.0000000000003388. Epub 2023 Feb 22.
We assess the efficacy, safety, and predictive factors for failure of synthetic mid-urethral slings for the treatment of urinary incontinence in a large cohort of women with neurogenic lower urinary tract dysfunction.
Women aged 18 years or older who received a synthetic mid-urethral sling for stress urinary incontinence or mixed urinary incontinence in 3 centers between 2004 and 2019 and who had a neurological disorder were included. Exclusion criteria were less than 1 year of follow-up, concomitant pelvic organ prolapse repair, previous synthetic sling implantation, and no baseline urodynamics. The primary outcome was surgical failure, defined as recurrence of stress urinary incontinence during follow-up. Kaplan-Meier analysis was used to estimate the 5-year failure rate. Adjusted Cox proportional hazard model was used to identify factors associated with surgical failure. Complications and reoperations during the follow-up have also been reported.
A total of 115 women with a median age of 53 years were included The median follow-up duration was 75 months. The 5-year failure rate was 48% (95 CI 46%-57%). Age above 50 years, negative tension-free vaginal tape test and transobturator route were associated with surgical failure. Thirty-six patients (31.3%) underwent at least 1 reoperation for complications or failure, and 2 required definitive intermittent catheterization.
Synthetic mid-urethral slings may be an acceptable alternative to autologous slings or artificial urinary sphincters for the treatment of stress urinary incontinence in a selected group of patients with neurogenic lower urinary tract dysfunction.
我们评估合成尿道中段吊带术治疗神经源性下尿路功能障碍的大量女性尿失禁患者的疗效、安全性及失败的预测因素。
纳入2004年至2019年间在3个中心接受合成尿道中段吊带术治疗压力性尿失禁或混合性尿失禁且患有神经系统疾病的18岁及以上女性。排除标准为随访时间不足1年、同时进行盆腔器官脱垂修复、既往有合成吊带植入史以及无基线尿动力学检查。主要结局为手术失败,定义为随访期间压力性尿失禁复发。采用Kaplan-Meier分析估计5年失败率。使用校正的Cox比例风险模型确定与手术失败相关的因素。还报告了随访期间的并发症和再次手术情况。
共纳入115名女性,中位年龄53岁。中位随访时间为75个月。5年失败率为48%(95%CI 46%-57%)。年龄大于50岁、无张力尿道中段吊带试验阴性和经闭孔途径与手术失败相关。36例患者(31.3%)因并发症或失败至少接受了1次再次手术,2例需要确定性间歇性导尿。
对于特定的神经源性下尿路功能障碍患者,合成尿道中段吊带术可能是自体吊带术或人工尿道括约肌治疗压力性尿失禁的可接受替代方法。